Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a value-based oncology services company that entered public markets through a business combination with DFB Healthcare Acquisitions Corp., a blank-check vehicle sponsored by DFB Healthcare Acquisitions LLC and led by healthcare-focused investors including Diego Miralles. DFB Healthcare Acquisitions Corp. completed its IPO in 2021, and the de-SPAC merger closed in late 2022, establishing TOI as a publicly traded oncology platform operating across the healthcare sector. The company filed an 8-K current report with the SEC on June 13, 2024, under accession number 0001079973-24-000876. For complete filing history, sponsor profiles, and deal analytics on TOI and the broader SPAC market, sign up for full data access at SpacDesk.